Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Novo Biosciences
AddedFeb 15, 2024
UpdatedJun 18, 2026
Novo Biosciences

Novo Biosciences

Series A

Novo Biosciences: Innovating cardiac drugs and cancer treatments for life-saving care.

HQ
Bar Harbor, ME, US
Founded
2013
Overview
Compare
Fundraising
Employees
Website

Novo Biosciences, founded with a mission to develop innovative cardiac drugs and cancer treatments, aims to reverse life-threatening damage caused by heart attacks and improve cancer care. The company's core vision is to provide life-saving medical solutions through advanced drug development. Novo Biosciences focuses on creating therapies that address critical health conditions, particularly in the cardiovascular and oncology sectors.

Notable affiliated individuals and investors include leading scientists and venture capital firms specializing in biotechnology. Novo Biosciences has achieved significant milestones in preclinical and clinical trials, demonstrating the efficacy of its cardiac drugs. The company's impact is marked by its potential to transform treatment paradigms for heart attack recovery and cancer therapy, contributing to improved patient outcomes and advancing medical science.

Novo Biosciences - Similar Companies

NovoMedix logo

NovoMedix

novomedix.com

Novita Pharmaceuticals logo

Novita Pharmaceuticals

novita-pharm.com

Novoron Bioscience logo

Novoron Bioscience

novoron.com

Cardurion Pharmaceuticals logo

Cardurion Pharmaceuticals

Nexo Therapeutics logo

Nexo Therapeutics

nexotx.com

Accunovo Biotechnologies logo

Accunovo Biotechnologies

NovoBiotic Pharmaceuticals logo

NovoBiotic Pharmaceuticals

novobiotic.com

Denovo Biopharma logo

Denovo Biopharma

Nuovo Biologics logo

Nuovo Biologics

nuovobiologics.com

Ventrinova logo

Ventrinova

Noveome Biotherapeutics logo

Noveome Biotherapeutics

noveome.com

Nerx Biosciences logo

Nerx Biosciences

NeoProgen logo

NeoProgen

Know Bio logo

Know Bio

knowbiollc.com

Bitterroot Bio logo

Bitterroot Bio

brbio.com

Novo Biosciences - Quick Facts

Who are Novo Biosciences' competitors?

Companies similar to Novo Biosciences include NovoMedix, Novita Pharmaceuticals, Novoron Bioscience and Cardurion Pharmaceuticals.

When was Novo Biosciences founded?

Novo Biosciences was founded in 2013.

Where is Novo Biosciences' headquarters located?

Novo Biosciences' headquarters is located in Bar Harbor, ME, US.

When was Novo Biosciences' last funding round?

Novo Biosciences' most recent funding round was for $4M (USD) in May 2020.

How much has Novo Biosciences raised to-date?

As of May 28, 2020, Novo Biosciences has raised a total of $5.6M (USD).

How many employees does Novo Biosciences have?

Novo Biosciences has 6 employees as of Feb 5, 2024.

Novo Biosciences - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Cancer Treatments
  • Cardiac Drugs
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified